CityUHK and Samsung Institute Forge Partnership for Health Innovation
On March 18th, the Institute of Digital Medicine (IDM) at City University of Hong Kong (CityUHK) and the Samsung Advanced Institute for Health Sciences & Technology (SAIHST) in Seoul, Korea, formalized a collaborative partnership. This alliance aims to advance health-related research, cultivate talent, and commercialize digital health solutions.
The Memorandum of Understanding (MoU) was signed by Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) at CityUHK, and Professor Chang Yun Sil, Director of SAIHST. This collaboration signifies a commitment to innovation in the field of digital medicine.
SAIHST, a leading institution co-established by the Samsung Group, Samsung Medical Center, and Sungkyunkwan University (SKKU), is focused on pioneering research and training experts in biomedical sciences. IDM, founded in April 2024, will leverage CityUHK’s research strengths in engineering, data science, and life sciences to find innovative solutions for digital health.
Professor Freddy Boey, President of CityUHK, emphasized the importance of global collaboration: “Global collaboration is crucial for the development of digital medicine. The partnership between IDM and SAIHST marks a significant milestone in advancing health technology innovation…” He added, “With CityUHK’s dynamic innovation and entrepreneurial ecosystem, I am confident that our joint efforts will empower our future leaders on the global stage and create a positive impact on Hong Kong, Korea, and beyond.”
The partnership will facilitate talent exchange. SAIHST will support top-tier researchers and scientists, while providing internship opportunities for CityUHK students. Both institutions will work together through CityUHK’s HK Tech 300 program, fostering deep-tech start-ups.
Following the signing, CityUHK’s IDM delegation met with SAIHST professors to discuss potential collaborations and knowledge-sharing. The partnership anticipates advancements in cell and gene therapy, bioinformatics, and biomedical engineering, all aimed at benefiting both healthcare professionals and patients.
